Echocardiographic or scintigraphic stress imaging with dipyridamole for the stratification of risk following acute myocardial infarction?;Ecocardiografia o scintigrafia da stress con dipiridamolo per la stratificazione del rischio dopo infarto miocardico acuto?

Giornale Italiano di Cardiologia

Volumn 27, Issue 9, 1997, Pages 908-914

  Desideri, Alessandro ^a   Candelpergher, Giovanni ^a   Zanco, Pierluigi ^a   Suzzi, Gian Leone ^a   Terlizzi, Raffaele ^a   Colangeli, Giovanna ^a   Favero, Adriano ^b   Ferlin, Giorgio ^a   Celegon, Leopolde ^a  

^a San Giacomo Hospital   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Acute infarction; Dipyridamole; Prognosis

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; DEATH; DRUG MEGADOSE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART REINFARCTION; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNSTABLE ANGINA PECTORIS;

EID: 0030821930     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. MULTICENTER POSTINFARCTION RESEARCH GROUP: Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336.
2. DE BUSK RF, BLOMQVIST CG, KOUGHOUKOS NT: Identification and treatment of low risk patients after acute myocardial infarction and coronary artery bypass graft surgery. N Engl J Med 1986; 314: 161-166.
3. STARLING MR, CRAWFORD MH, KENNEDY GT, ET AL: Exercise testing after myocardial infarction: predictive value for subsequent unstable angina and death. Am J Cardiol 1980; 46: 909-914.
4. THEROUX P, WATERS D, HALPHEN C, ET AL: Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979; 301: 341-345.
5. EPSTEIN SE, PALMIERI ST, PATTERSON RE: Evaluation of patients after acute myocardial infarction: indications for cardiac catheterization and surgical interventions. N Engl J Med 1982; 307: 1482-1487.
6. CAMPBELL S, A'HERN R, QUIGLEY P, ET AL: Identification of patients at low risk of dying after acute myocardial infarction by simple clinical and submaximal exercise test criteria. Eur Heart J 1988; 9: 938-947.
7. VELASCO J, TORMO V, FERRER LM, ET AL: Early exercise test for evaluation of long term prognosis after uncomplicated myocardial infarction. Eur Heart J 1981; 2: 401-407.
8. WELD FM, CHU KL, BIGGER JY JR, ET AL: Risk stratification with low level exercise testing two weeks after acute myocardial infarction. Circulation 1981; 64: 306-314.
9. DE BELDER MA, PUMPHREY CW, SKEHAN JD, ET AL: Relative power of clinical, exercise test, and angiographic variables in predicting clinical outcome after myocardial infarction: the Newham and Tower Hamlets Study. Br Heart J 1988; 60: 377-389.
10. LEPPO JA, O'BRIEN J, ROTHENDLER JA, ET AL: Dipyridamole thallium 201 scintigraphy in the prediction of future cardiac events after myocardial infarction. N Engl J Med 1984; 310: 1014-1018.
11. PIRELLI S, INGLESE E, SUPPA M, ET AL: Dipyridamole thallium 201 scintigraphy in the early post-infarction period. Eur Heart J 1988; 9: 1324-1331.
12. BROWN KA, WEISS RM, CLEMENTS JP, ET AL: Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction. Am J Cardiol 1987; 60: 15-19.
13. BROWN KA, O' MEARA J, CHAMBERS CE, ET AL: Ability of dipyridamole thallium 201 imaging 1 to 4 days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol 1990; 65: 160-167.
14. GIMPLE LW, HUTTER AM, GUINEY TE, ET AL: Prognostic utility of predischarge dipyridamole thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated myocardial infarction. Am J Cardiol 1989; 64: 1243-1248.
15. MURRAY DP, MURRAY G, RAFIQI E, ET AL: Routine exercise testing or thallium 201 scintigraphy for prediction of cardiac events post myocardial infarction? Eur J Nucl Med 1987; 13: 274-277.
16. OKADA R, GLOVER D, LEPO J: Dipyridamole 201 Tl scintigraphy in the evaluation of prognosis after myocardial infarction. Circulation 1991; 84 (3): 1132-1139.
17. BOLOGNESE L, SARASSO G, BONGO A, ET AL Stress testing in the period after infarction. Circulation 1991; 83 (Suppl III): 32-37.
18. BOLOGNESE L, ROSSI L, SARASSO G, ET AL: Silent versus symptomatic dipyridamole induced ischemia after myocardial infarction: clinical and prognostic significance. J Am Coll Cardiol 1992; 19: 953-959.
19. PICANO E, LANDI P, BOLOGNESE L, ET AL: Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large scale, multicenter trial. Am J Med 1995; 6: 608-618.
20. CAMERIERI A, PICANO E, LANDI P: Prognostic value of dipyridamole echocardiography early after myocardial infarction in the elderly patients. J Am Coll Cardiol 1993; 22 (7): 1809-1815.
21. SCLAVO MG, NOUSSAN P, PALLISCO O, PRESBITERO P: Usefulness of dipyridamole-echocardiograprhic test to identify jeopardized myocardium after thrombolysis. Eur Heart J 1992; 13: 1348-1355.
22. CHIARELLA F, DOMENICUCCI S, BELLOTTI P: Dipyridamole echocardiographic test performed three days after an acute myocardial infarction: feasibility, tolerability and in-hospital prognostic value. Eur Heart J 1994; 15 (6): 842-850.
23. PICANO E, PINGITORE A, SICARI R, ET AL: Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large scale multicenter study. J Am Coll Cardiol 1995; 26: 908-913.
24. ZANCO P, ZAMPIERO A, FAVERO A, ET AL: Myocardial technetium 99m sestamibi single-photon emission tomography as a prognostic tool in coronary artery disease: multivariate analysis in a long term prospective study. Eur J Nucl Med 1995; 22: 1023-1028.
25. SAS INSTITUTE INC., SAS LANGUAGE: Reference, version 6, first edition Cary. North Carolina, SAS Institute Inc., 1990.
26. VAN DAELE M, Mc NEIL A, FIORETTI P, ET AL: Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. J Am Soc Echocardiogr 1994; 7 (4): 370-380.
27. OLONA M, CANDELL-RIERA J, PERMANYER-MIRALDA G, ET AL: Strategies for prognostic assessment of uncomplicated first myocardial infarction: 5 year follow-up study. J Am Coll Cardiol 1995; 25: 815-822.
28. TRAVIN M, DESSOUKI A, CAMERON T, ET AL: Use of exercise technetium 99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995; 75: 665-669.
29. KRONE RJ, GILLESPIE JA, WELD FM: Low level exercise testing after myocardial infarction: usefulness in enhancing clinical risk stratification. Circulation 1985; 71: 80-89.
30. FROEHLICHER VF, PERDUE S, PEWEN W, ET AL: Application of meta-analysis using an electronic spread sheet to exercise testing in patients after myocardial infarction. Am J Med 1987; 83: 1045-1054.
31. MAURI F, CANONICO A, CIRRINCIONE V, ET AL: Inquadramento prognostico pre-dimissione del paziente infartuato. In: ANMCO-SIC (eds): Linee guida sulla cardiopatia ischemica acuta, 1996; 54-61.